Microfluidics Market Focusing On The Basis Of Technology, Material, Application, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 18 Dec 2023: The Report Microfluidics Market Size, Share & Trends Analysis Report By Application (Medical/Healthcare, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2024 – 2030

The global microfluidics market size is expected to reach USD 71.90 billion by 2030, registering CAGR of 12.22% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for microfluidics-based devices is expected to increase due to the introduction of improved technology such as digital microfluidics, which enables on-chip biochemical analysis. An increase in research activities undertaken by analytical and clinical researchers have also driven the demand for microfluidics device. For instance, in May 2022, a research team from the University of Minnesota developed an innovative microfluidic chip for disease diagnosing that uses a minimum number of components and can be operated wirelessly by a smartphone.

Miniature microfluidic-based tools are gaining significant popularity among consumers, which has encouraged companies to invest in their development. Since microfluidics is the underlying principle of lab-on-a-chip devices, it offers various benefits such as minimal sample volume, minimal reagent usage, reduced waste, and rapid processing. Fully automated microfluidics with enhanced functional capabilities, and robust modularity are creating growth opportunities for manufacturers operating in the market. This can be attributed to the fact that modular chips can interface with several instruments. In addition, companies operating in the field of drug discovery are striving to minimize overhead costs and timelines to offset the estimated decline in revenue owing to a significant number of drugs going off-patent.

The implementation of microfluidics is expanding in the field of diagnostics, especially in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. The combination of microfluidic components with POC devices is largely focused on achieving sensitivity, stability, accuracy, affordability, and obtaining minimally invasive POC technology. Microfluidic POC technologies are expected to enhance patient care by ensuring personalization, early disease detection, and easy monitoring.

In addition, COVID-19 has further upscaled the use of microfluidics. Point-of-care testing involves small equipment, regulates the process, and has limited testing cycles. This allows single or multiple research laboratory services to evaluate biological samples and diagnose harmful diseases simultaneously. In general, stage assessment and rapid detection of viral epidemics are vital to overcoming pandemic situations and diagnosing rapidly. Therefore, combining microfluidic devices with point-of-care testing enhances detection efficiency. At the same time, point-of-care testing of microfluidic chips enhances user accessibility, improves sensitivity and accuracy, and reduces the detection time, all of which are advantageous in detecting SARS-CoV-2.

Further, several acquisitions in the microfluidics industry are aimed at enhancing technologies for expanding the scope of microfluidics-related applications. In June 2021, Danaher Corporation announced that Precision NanoSystems (PNI), a Canada-based solution provider, was acquired by its life science business. PNI offered proprietary genetic toolkit platforms, including LNP delivery and nanoparticle manufacturing via the microfluidic-based platform, which further complemented the company’s portfolio of life science products.

On the other hand, high operational costs hinder the microfluidics market growth to a certain extent. The fabrication of microfluidics chips has certain issues such as open channel construction that require bonding of machine parts to form a final enclosed structure. The open channel is formed by the etching of glass or silicon. This step is slow, costly, and requires the use of aggressive chemicals. In addition, most of the microfluidic prototyping methods are not compatible with the batch process, and are also complicated and costly.

Access Research Report of Microfluidics Market @ https://www.grandviewresearch.com/industry-analysis/microfluidics-market

Microfluidics Market Report Highlights

• Based on application, the medical segment held the highest revenue share of the market in 2023 and is expected to exhibit a CAGR of 12.56% from 2024-2030.
• Based on material, the polydimethylsiloxane (PDMS) segment held the highest market share in 2023 and is expected to grow at a CAGR of 13.59% from 2024-2030.
• Based on technology, the lab-on-a-chip segment dominated the market in 2023 and is expected to reveal a CAGR of 11.06% during the forecast period.
• North America dominated the market with a revenue share of 42.69% in 2023 and is projected to exhibit a CAGR of 10.57% during the forecast period.

Microfluidics Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 36.00 billion
Revenue forecast in 2030	USD 71.90 billion
Growth rate	CAGR of 12.22% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 – 2022
Forecast period	2024 – 2030

List of Key Players of Microfluidics Market

• Illumina, Inc.
• Hoffmann-La Roche Ltd
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Abbott
• Thermo Fisher Scientific
• Standard BioTools

Access Press Release of Microfluidics Market @ https://www.grandviewresearch.com/press-release/global-microfluidics-market

Medical Simulation Market Outlook On The Basis Of Products & Services, Technology, End Use, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 13 Dec 2023: The Report Medical Simulation Market Size, Share & Trends Analysis Report By Product & Services (Medical Simulation Software, Web-based Simulators, Simulation Training Services), By Technology, By End Use, And Segment Forecasts, 2023 – 2030

The global medical simulation market size is expected to reach a value of USD 7.49 billion by 2030. The market is expected to expand at a CAGR of 16.7% from 2023 to 2030. With recent technological advancements, the use of new medical devices and advanced procedures, such as enhanced mechanical ventilation devices, cardiac assist devices, and intra-cardiac echocardiography technology, is increasing; which drives the need for advanced training solutions, such as simulation, for customer training and internal product development. Certification and regulatory agencies are strictly recommending that physicians and clinicians be trained before the adoption of new, disruptive technologies. Although hands-on learning with real patients cannot be replaced, simulation training offers safe learning conditions. Students and medical residents making mistakes in this phase is an important part of the learning process, as in simulation training patients are not put at risk.

Education Management Solutions, LLC- a company dealing in medical simulation learning management technology-released workflows that were COVID-19 contingency ready for healthcare education. CAE Healthcare responded to the pandemic by helping with a complimentary webinar, SCE, and outreach toolkit to assist educators. Such factors boosted the demand for medical simulation services during the pandemic.

The market is very competitive. The most notable market participants are CAE, Laerdal Medical, 3D Systems, Simulab Corporation, Limbs & Things Ltd, Mentice AB, Simulaids, Gaumard Scientific Company, Surgical Science Sweden AB, Kyoto Kagaku Co., Ltd and account for a considerable share owing to their product offerings to the market. Market leaders are involved in the establishment of extensive distribution systems as well as in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Gaumard Scientific Company revealed its ultrasound system and pediatric emergency scenario modules for Pediatric HAL.

Access Research Report of Medical Simulation Market @ https://www.grandviewresearch.com/industry-analysis/medical-healthcare-simulation-market

Medical Simulation Market Report Highlights

• Healthcare anatomical model dominated the products and services segment of the overall market in 20222, as these simulators are proving to be beneficial in the manufacturing and research industry for conducting trials
• The hospitals end-user segment is expected to expand at the fastest CAGR of 16.6% over the forecast period. Factors responsible for the growth are the gradual shift of focus on advanced learning and increasing focus on minimizing errors
• Procedural rehearsal technology is expected to be the largest technology segment. The rising number of medical errors leading to increasing demand for patient safety is expected to boost the demand for procedure rehearsal technology
• The Asia Pacific region is anticipated to register rapid growth in the forthcoming years owing to the growing healthcare IT spending and rapidly evolving healthcare infrastructure
• Key players operating in this market include CAE, 3D Systems, Limbs & Things Ltd, Mentice AB, and Surgical Scientific Sweden AB
• In February 2022, Surgical Science joined Mimic Technologies, thus expanding its foothold in the robotic surgery segment

Medical Simulation Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 2.5 billion
Revenue forecast in 2028	USD 7.49 billion
Growth Rate	CAGR of 16.7% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 – 2021
Forecast period	2023 – 2030

List of Key Players in the global Medical Simulation Market

• CAE (Canadian Aviation Electronics, Ltd)
• Laerdal Medical
• 3D Systems
• Simulab Corporation
• Limbs & Things Ltd
• Simulaids
• Kyoto Kagaku Co., Ltd
• Gaumard Scientific Company
• Mentice AB
• Surgical Science Sweden AB

Access Press Release of Medical Simulation Market @ https://www.grandviewresearch.com/press-release/global-medical-healthcare-simulation-market

Interventional Cardiology Devices Market Trends Analysis Report By Product, Region And Forecast To 2028: Grand View Research Inc.

San Francisco, 12 Dec 2023: The Report Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 – 2030

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research Inc. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe. 

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Access Research Report of Interventional Cardiology Devices Market @ https://www.grandviewresearch.com/industry-analysis/interventional-cardiology-devices-market-analysis

Interventional Cardiology Devices Market Report Highlights

• The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.
• Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
• Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
• The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence 

Interventional Cardiology Devices Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 13.75 billion
Revenue forecast in 2030	USD 22.35 billion
Growth Rate	CAGR of 7.2% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 – 2021
Forecast period	2023 – 2030

List of Key Players of Interventional Cardiology Devices Market

• Abbott Laboratories
• Medtronic
• Boston Scientific
• Spectranetics
• Cardinal Health
• Philips Healthcare
• Terumo
• Alvimedica
• Teleflex Medical
• Braun
• Biosensors International
• Meril Life Sciences
• BIOTRONIK
• ACIST Medical Systems
• ASAHI INTECC
• CID Vascular
• Cook Medical
• Medinol
• Merit Medical Systems
• NuMED
• OpSens
• Vascular Solutions
• Zeon Medical

Access Press Release of Interventional Cardiology Devices Market @ https://www.grandviewresearch.com/press-release/global-interventional-cardiology-devices-market

Healthcare Cyber Security Market Focusing On The Basis Of Type Of Solutions, Type Of Threats, End Use, Type Of Security, Deployment, Region And Forecast 2028: Grand View Research Inc.

San Francisco, 6 Dec 2023: The Report Healthcare Cyber Security Market Size, Share & Trends Analysis Report By Type Of Solution, By Type Of Threat, By End Use, By Type of Security, By Deployment, By Region, And Segment Forecasts, 2023 – 2030

The global healthcare cyber security market size is expected to reach USD 56.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 18.4% from 2023 to 2030. An increasing number of cyber-attacks in the healthcare industry, a raise in threats, and concern for privacy and security are contributing to the growth of the market. The increase in cases of cyber-attacks and data breaches globally has raised the concern thereby, increasing demand for cyber security. For instance, the Secretary of U.S. Department of Health and Human Services (HHS) Breach of Unsecured Protected Health Information listed 592 breaches of unsecured protected health data affecting more than 500 individuals within the last two years that are currently under investigation by the Office for Civil Rights. 306 of the breaches were submitted in 2020.

The Healthcare sector is prone to various cyber-attacks. The increasing digitalization and adoption of the internet are increasing the chances of the cyber-attacks on the healthcare industry as it is the most vulnerable to such attacks due to the sensitive nature of the data. In 2021, a phishing assault at Monongalia Health System in West Virginia resulted in a data breach, allowing hackers access to multiple email accounts at the institution. Following an examination, it was discovered that unauthorized persons had entered a contractor’s email account and sent emails seeking to gain payments from Mon Health through fraudulent wire transfers. Such events may be indicative of a lax cyber security policy.

To prevent the spread of COVID-19, healthcare practitioners enhanced their telehealth services and began depending on remote access technologies for public health emergencies during the pandemic. This has promoted excessive usage of the internet while compelling medical-treatment facilities to use remote-care equipment that lacks adequate security, increasing the potential for assaults. Hackers and fraudsters are capitalizing on the turmoil of the COVID-19 situation with cyber threats like phishing scams and ransomware attacks.

The circumstance changed in unanticipated ways and the companies operating in the industry are adapting to a new reality, predicting, and planning for numerous possibilities. As a result, healthcare companies are relying on sophisticated cyber security technologies for protection from such attacks. Several top cyber security businesses see this crisis as a new chance to restructure and reassess their present strategy, as well as advance their product portfolio. Indeed, the pandemic has increased opportunities for the market to grow exponentially in the coming years. Furthermore, technological advancements in the development of different products to control cyber-attacks and safeguard the data are expected to boost market growth. For instance, in February 2020, GE Healthcare introduced a new cyber security solution known as Skeye for hospitals for detecting, analyzing, and responding to security threats in real-time.

Access Research Report of Healthcare Cyber Security Market @ https://www.grandviewresearch.com/industry-analysis/healthcare-cyber-security-market

Healthcare Cyber Security Market Report Highlights 

• Based on the type of solution, the antivirus and antimalware segment dominated the market and accounted for a revenue share of over 25.6% in 2022 due to the increase in the adoption of such solutions in healthcare settings. It is attributed to a surge in the number of malware attacks in the healthcare industry, which are capable of shutting down the hospital networks thereby affecting patient care
• Based on type of threat segment, the malware segment dominated the market and accounted for the largest revenue share of around 25.4% in 2022. The ransomware attack is the extensively used malware type due to the awareness and preferences of the hackers for ransomware
• Based on end-use segment, the hospital segment held the largest revenue share of around 62.9% in the year 2022. Hospitals are extremely vulnerable to the cyber-attack as it stores an incredible amount of patient data. In addition, these attacks are spiked during the pandemic threatening private data and patient care
• As of 2021, North America dominated the market and accounted for the largest revenue share of over 40%. The key attributing factors for the market growth are the presence of key players and the increased application of cyber security in healthcare organizations
• In the Asia Pacific, the market is anticipated to witness lucrative growth over the forecast period due to the increased adoption and penetration of the internet in the healthcare industry

Healthcare Cyber Security Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 17.3 billion
Revenue forecast in 2030	USD 56.3 billion
Growth Rate	CAGR of 18.4% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 – 2021
Forecast period	2023 – 2030

List of Key Players of Healthcare Cyber Security Market 

• Cisco
• IBM
• FireEye
• Symantec
• Trend Micro
• MacAfee
• Intel
• Kaspersky
• Lockheed Martin
• Northrop Grumman
• Imperva Inc
• Fortinet Inc
• Medigate Ltd

Access Press Release of Healthcare Cyber Security Market @ https://www.grandviewresearch.com/press-release/global-healthcare-cyber-security-market

Dental Equipment Market Segment Analysis By Product, Region And Forecast Till 2030: Grand View Research Inc.

San Francisco, 4 Dec 2023: The Report Dental Equipment Market Size, Share & Trends Analysis Report By Product (Dental Radiology Equipment, Laboratory Machines, Dental Lasers, Systems & Parts, Hygiene Maintenance Devices, Other Equipment), By Region, And Segment Forecasts, 2024 – 2030

The global dental equipment market size was estimated at USD 17.06 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2030. These tools help with an oral health diagnosis, care, and maintenance and allow practitioners to plan a precise course of action. The introduction of supportive government efforts for oral health, an increase in medical tourism for dental operations, and the incidence of dental problems all contribute to the industry’s growth. In addition, manufacturers like Planmeca are always introducing fresh computer-aided technology to the market.

For instance, the industry demand is being driven by the company’s March 2019 launch of the Planmeca Creo C5, an innovative 3D printer created to deliver chairside CAD/CAM dentistry and restorative dental treatments in a single visit.According to the estimates published by the United Nations in 2019, there were 703 million people aged over 65 years globally, and the number of older individuals is projected to double to 1.5 billion by 2050. The rising prevalence of various oral conditions in the geriatric population is likely to increase the demand for preventive, restorative, and surgical services in the future. According to the American Dental Association, 85% of individuals in the United States, value dental health and consider it an essential aspect of overall care.

The realization of the importance and maintenance of oral health combined with better access to advanced dental services will help in the growth of the industry. However, the “emergency-only” mode of dental care delivery due to the COVID-19 pandemic had a rippling effect and the industry witnessed an imminent increase in availing cost of dental care. According to the Journal of Contemporary Dental Practice, dental services were among the last to relaunch in post-pandemic relaxations since dental procedures are at high risk of transmission. This resulted in serious financial problems and revenue loss for the overall dental market.

Access Research Report of Dental Equipment Market @ https://www.grandviewresearch.com/industry-analysis/dental-equipment-market

Dental Equipment Market Report Highlights

• Dental systems and parts emerged as the largest product segment in 2022 as these equipment are used for digital imaging and diagnosis of dental ailments
• The dental lasers segment is expected to witness the highest CAGR during the forecast period. This is owing to its increasing application in surgical and teeth-whitening procedures.
• North America dominated the global industry in 2022 owing to the high demand for new technologies & the prevalence of dental disorders and the presence of a large pool of key players & advanced healthcare infrastructure
• Asia Pacific, on the other hand, is expected to register the highest CAGR over the forecast period

Dental Equipment Market Report Scope

Report Attribute	Details
Market size value in 2024	USD 11.81 billion
Revenue forecast in 2030	USD 17.06 billion
Growth rate	CAGR of 6.3% from 2024 to 2030
Base year for estimation	2023
Historical data	2018 – 2022
Forecast period	2024 – 2030

List of Key Players in Dental Equipment Market

• A-Dec Inc.
• Planmeca Oy
• Dentsply Sirona
• Patterson Companies Inc.
• Straumann
• GC Corp.
• Carestream Health Inc.
• Biolase Inc.
• Danaher Corp.
• 3M EPSE

Access Press Release of Dental Equipment Market @ https://www.grandviewresearch.com/press-release/global-dental-equipment-market

Contact Center Software Market Focusing On The Basis Of Solution, Service, Deployment, Enterprise Size, End-Use, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 1 Dec 2023: The Report Contact Center Software Market Size, Share & Trends Analysis Report By Solution, By Service, By Deployment (Hosted, On-premise), By Enterprise Size, By End-use (BFSI, Government, Healthcare, IT & Telecom), By Region, And Segment Forecasts, 2023 – 2030

The global contact center software market size is expected to reach USD 149.58 billion by 2030, expanding at a CAGR of 23.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. The contact center software market encompasses software and services used by organizations to streamline business processes and enhance customer interactions. It involves real-time call monitoring, agent assignment, and centralized reporting for improved efficiency. Contact center software plays a crucial role in facilitating effective communication between contact center workers and clients, leading to enhanced productivity.

The strong emphasis businesses are putting on leveraging the advances in the latest technologies and integrating Artificial Intelligence (AI) and machine learning into their business processes is expected to drive the market further. For instance, in May 2023, Anthropic, an AI safety and research company, and Zoom, a video communication platform provider, established a partnership where Anthropic’s generative AI model would be integrated into Zoom’s Contact Center portfolio. As part of this collaboration, Zoom also made an investment in Anthropic, although specific details regarding the amount and terms of the investment were not disclosed.

The adoption of advanced technologies such as cloud-based solutions and AI has emerged as a key driver for the contact center software market. Cloud-based solutions offer scalability, flexibility, and cost-effectiveness, allowing organizations to easily manage and scale their contact center operations. AI-powered features like chatbots, natural language processing, and sentiment analysis enhance customer interactions by providing personalized and efficient support. These technologies not only improve customer satisfaction but also contribute to operational efficiency, enabling contact centers to handle a higher volume of inquiries and optimize agent productivity.

The COVID-19 pandemic has had a significant positive impact on the contact center software market. With the sudden shift towards remote work and the need for virtual customer service solutions, organizations across various industries have turned to contact center software to ensure uninterrupted customer support. The pandemic has highlighted the importance of robust and flexible contact center solutions that can be accessed remotely. As a result, businesses have invested heavily in contact center software to enable their agents to work from home and continue providing seamless customer service.

Access Research Report of Contact Center Software Market @ https://www.grandviewresearch.com/industry-analysis/contact-center-software-market

Contact Center Software Market Report Highlights

• The customer collaboration segment is expected to witness significant growth over the forecast period. Customer collaboration solutions are widely used by businesses to streamline communication between customers and relevant departments. Customer collaboration tools are instant, effective, and convenient to use and can potentially simplify two-way interaction. Businesses are adopting customer collaboration solutions to quickly track, receive, and resolve customer support queries
• The managed services segment is expected to witness significant growth over the forecast period. Managed services help in managing business infrastructure and application platforms. These services can particularly help the customer service team in quickly identifying faults, isolating the root cause of infrastructure outages, and subsequently, working more reliably and efficiently. Businesses opt for managed services to effectively manage their complex IT infrastructure
• The growing expenses being incurred on on-premise systems amid a highly competitive business environment are prompting businesses to switch to cloud-based solutions. Cloud-based contact center solutions can effectively handle all outbound and inbound communications while offering an all-inclusive suite of applications and tools that can allow businesses to deliver efficient customer service across multiple channels, including SMS, email, voice, and social media
• The increasing adoption of emerging technologies by large enterprises to automate repetitive tasks and improve operational efficiency is driving the demand for contact center solutions in large enterprises. As organizations strive to enhance productivity and streamline their customer service operations, the need for advanced contact center solutions is projected to grow significantly
• Consumer goods and retail businesses are focusing on strengthening their multichannel interactions with employees and customers. The rising popularity of online shopping is further driving the need for continuous customer service facilities, which in turn, is expected to propel the adoption of contact center solutions by the incumbents of the consumer goods & retail industry
• Asia Pacific is anticipated to emerge as the fastest-growing regional market owing to a broader customer base and the presence of a substantial number of small and medium enterprises in the region. Intensifying competition between the local and international companies is also expected to propel the adoption of contact center solutions

Contact Center Software Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 33.38 billion
Revenue forecast in 2030	USD 149.58 billion
Growth rate	CAGR of 23.9% from 2023 to 2030
Base year of estimation	2022
Historical data	2017 – 2021
Forecast period	2023 – 2030

List of Key Players in the Contact Center Software Market

• 8X8, Inc.
• ALE International
• Altivon
• Amazon Web Services, Inc.
• Ameyo
• Amtelco
• Aspect Software
• Avaya Inc.
• Avoxi
• Cisco Systems, Inc.
• Enghouse Interactive Inc.
• Exotel Techcom Pvt. Ltd.
• Five9, Inc.
• Genesys
• Microsoft Corporation
• NEC Corporation
• SAP SE
• Spok, Inc.
• Talkdesk, Inc.
• Twilio Inc.
• UiPath
• Unify Inc.
• VCC Live

Access Press Release of Contact Center Software Market @ https://www.grandviewresearch.com/press-release/global-contact-center-software-market

Clinical Decision Support Systems Market Segmented On The Basis Of Product, Application, Delivery Mode, Component, Region And Forecast 2028: Grand View Research Inc.

San Francisco, 30 Nov 2023: The Report Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2023 – 2030

The global clinical decision support systems market size is anticipated to reach USD 10.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.6% from 2023 to 2030. Surging demand for quality care is one of the primary factors augmenting the market. Constant lookout for reliable technology solutions by care providers is also expected to work in favor of the market. The growing interest in enhanced medical care and efficient decision-making is projected to fuel the adoption of clinical decision support systems (CDSS) and EHR.

To manage the COVID-19 pandemic, many initiatives are being undertaken by government and community organizations to support the current healthcare system. These comprise front-line clinics by state governments, volunteer panels of doctors, and many private telemedicine applications. CDSS is playing a vital role during the pandemic, by helping physicians make effective choices at the point of care. As a result, market players are capitalizing on this opportunity to address the problem and provide support to front-line doctors.

For instance, in May 2021, DHIndia announced a collaboration with EHRC@IIITB & Healthelife to develop CDSS for COVID-19 screening. This collaboration also included the formation of a minimal triage application for front-line clinicians.

Decision support in critical health situations proves to be significant. Furthermore, these systems analyze patient medical records and provide a list of possible solutions from which the most appropriate is to be selected. Easy compatibility and interoperability of systems with different platforms have enhanced the growth prospects of the market. Collaborative efforts of researchers and software developers to make medical knowledge available to users are anticipated to contribute to lucrative revenue generation during the forecast period.

CDSS is currently being used in a variety of healthcare operations, including diagnosis, drug prescription, and clinical studies. According to the NCBI in 2020, clinical and diagnostic coding, procedure and test ordering, and patient triage are all supported by CDSS. Developed algorithms can provide a refined list of diagnostic codes to help clinicians choose the most appropriate one. A CDSS was created to overcome the inaccuracy of ICD-9 admission coding in emergency departments (EDs) (ICD is the International Statistical Classification of Diseases, standardized codes used to represent diseases and diagnoses).

CDSS helps ED physicians to identify diagnostic admission codes more quickly. Furthermore, the significance of CDSS has been recognized across several healthcare entities, including public & private healthcare sectors. Also, healthcare organizations are launching programs to promote EHR & CDSS installation and integration, which is projected to have a favorable impact on the market by encouraging hospitals and healthcare groups to use such systems.

Access Research Report of Clinical Decision Support Systems Market @ https://www.grandviewresearch.com/industry-analysis/clinical-decision-support-system-market

 Clinical Decision Support Systems Market Report Highlights

• Standalone CDSS accounted for the largest share of market revenue in 2022 owing to its low cost. The segment is estimated to hold approximately 30.0% of the overall market by 2030
• The CDSS integrated with EHR segment is poised to experience noteworthy growth in the coming years due to the rapid adoption of healthcare IT solutions by clinicians
• Drug allergy alerts made the highest contribution to market revenue generation in 2022 owing to the rising burden of allergies
• In terms of revenue, the on-premises segment dominated the overall industry with a share of over 43.0% in 2022, owing to its high adoption rate by healthcare organizations
• CDSS software segment is poised for lucrative growth during the forecast period owing to novel innovations for technical support and interoperability of the CDSS software
• Domicile of a large number of key players and high adoption rate of advanced technologies are anticipated to contribute to the dominance of the North American region in the coming years. However, Asia Pacific is estimated to witness the highest CAGR of 13.5% during the forecast period
• Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other
• For instance, in October 2021, DreaMed Diabetes AI Ltd. proclaimed that it had received FDA Clearance for its Type 2 Diabetes AI-based CDSS, thereby enhancing its offerings

Clinical Decision Support Systems Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 5.3 billion
Revenue forecast in 2030	USD 10.7 billion
Growth rate	CAGR of 10.6% from 2023 to 2030
Base year for estimation	2022
Actual estimates/Historical data	2017 – 2021
Forecast period	2023 – 2030

List of Key Players in the Clinical Decision Support Systems (CDSS) Market

• McKesson Corporation
• Cerner Corporation
• Siemens Healthineers GmbH
• Allscripts Healthcare, LLC
• athenahealth, Inc.
• NextGen Healthcare Inc.
• Koninklijke Philips N.V. (Royal Philips)
• IBM Corporation
• Agfa-Gevaert Group (IG Farben)
• Wolters Kluwer N.V.

Access Press Release of Clinical Decision Support Systems Market @ https://www.grandviewresearch.com/press-release/global-clinical-decision-support-system-cdss-market

Biopsy Devices Market Segmented On The Basis Of Product, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 29 Nov 2023: The Report Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2023 – 2030

The global biopsy devices market size is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Introduction of technologically advanced products, leading to increasing adoption of minimally invasive surgical procedures, is the key factor driving the market.

In addition, growing investments in the oncology field by government and non-government organizations are expected to positively impact market growth. For instance, in 2022, the American Institute for Cancer Research funded more than $110 million for research to ensure a future without cancer. Moreover, the organization supports the establishment of an Advanced Research Projects Agency for Health (ARPA-H) that is focused on accelerating cancer and biomedical research translation.

The COVID-19 pandemic led to a significant drop in biopsy procedures, especially in the first half of the pandemic. This represented a temporary negative impact on the sales of biopsy devices. The major factor responsible for this moderate downfall in sales was reduced patient visits to healthcare institutes as a precautionary measure to avoid being infected with the virus.

With economies returning to normalcy and the healthcare sector going back to majorly focusing on cancer research, the market recovered at a rapid pace. The biopsy market is further expected to witness significant growth over the forecast period due to constant advancements in the field of oncology and diagnostics.

Access Research Report of Biopsy Devices Market @ https://www.grandviewresearch.com/industry-analysis/biopsy-devices-industry

Biopsy Devices Market Report Highlights

• Needle-based biopsy guns held the largest market share in 2022 owing to surging demand for these devices to acquire samples from soft tissues
• New product launches of vacuum-assisted biopsy devices are further expected to accelerate the demand for needle-based biopsy guns over the forecast period
• The biopsy needles segment is expected to register a significant CAGR over the forecast period. It represents lucrative growth opportunities owing to the increasing adoption of these products and the launch of advanced products
• North America dominated the market in 2022 due to the high penetration rate of technologically advanced products and the presence of key market players in the region
• The rising incidence of cancer coupled with high unmet patient needs is expected to propel the growth of the market extensively in the Asia Pacific region

Biopsy Devices Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 2.25 billion
Revenue forecast in 2030	USD 3.64 billion
Growth rate	CAGR of 7.1% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 – 2021
Forecast period	2023 – 2030

List of Key Players in the Biopsy Devices Market

• Cardinal Health Inc.
• Hologic, Inc.
• Danaher Corporation
• CONMED Corporation
• Cook Medical
• DTR Medical
• INRAD, Inc.
• Devicor Medical Products Inc.
• Gallini Srl
• TransMed7, LLC

Access Press Release of Biopsy Devices Market @ https://www.grandviewresearch.com/press-release/biopsy-devices-market

Bioanalytical Testing Services Market Segmented On The Basis Of Product, Application, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 28 Nov 2023: The Report Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small, Large), By Test (Bioavailability, Bioequivalance), By Workflow (Sample Analysis, Sample Preparation), And Segment Forecasts, 2023 – 2030

The global bioanalytical testing services market size is expected to reach USD 7,645.7 million by 2030, according to a new report by Grand View Research, Inc. registering a CAGR of 8.7% over the forecast period. The increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted the demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe.

Furthermore, the growing demand for pharmaceutical products across the globe has resulted in a surge of pipeline drugs that require bioanalytical testing for development, thus augmenting the market growth. In addition, the market is expected to witness considerable growth over the forecast period owing to the increasing number of contract manufacturing companies expanding their development capacities across the globe. Hence, the growing volume of batch production of biologics is further supported by such initiatives. The outbreak of COVID-19 infection has further offered lucrative growth opportunities for the market to flourish amidst the pandemic. The outbreak of the COVID-19 virus has resulted in a sudden robust demand for appropriate vaccines, which requires extensive analytical testing.

To meet the rapid demand, major pharmaceutical companies have approached the contract development and manufacturing organizations for fast-track analysis and development of the appropriate drug in the treatment of COVID-19 infection, thus boosting the growth of bioanalytical testing services across the globe, also, major pharmaceutical giants are focusing on expanding bioanalytical testing capabilities to ensure rapid production of COVID-19 vaccines, which, in turn, supported significant growth in revenue generation during 2020.

For instance, in February 2021, Nexelis, a provider of advanced assay development and laboratory testing services, has signed an asset purchase agreement with GlaxoSmithKline (GSK) to acquire GSK’s Good Clinical Laboratory Practices (GCLP)-certified clinical bioanalytical laboratory located in Marburg, Germany, with an aim to enhance its vaccines production capacities. In terms of molecules, the market is classified into small and large molecules. The large molecules segment is further segmented into LC-MS studies, immunoassays, and others based on test type. The small molecule-based bioanalytical testing services are estimated to hold the highest share over the forecast period.

Branded and generic drug compounds are mostly small molecules. In addition, these molecules bind easily with the targets present in intracellular regions. These factors are expected to fuel segment growth. On the other hand, large molecule bioanalytical testing services are expected to grow at the fastest rate during the forecast period. A strong biologic and amino acid-based product pipeline is expected to propel the overall market growth. For instance, major pharmaceutical companies, such as AstraZeneca, reported a total of 17 new molecular entities in their late-stage pipeline, among them majority are large molecule biologics.

Access Research Report of Bioanalytical Testing Services Market @ https://www.grandviewresearch.com/industry-analysis/bioanalytical-testing-services-market

Bioanalytical Testing Services Market Report Highlights

• The small molecule segment accounted for the largest revenue share of over 55.9% in 2022. The high demand for generic drug development boosts the segment growth
• The bioequivalance segment is estimated to witness the fastest CAGR during the forecast period
• An increasing rate of drug manufacturing outsourcing services is estimated to fuel the growth of this segment
• The sample preparation segment held a significant market share in 2022 and is estimated to expand further at the fastest CAGR from 2023 to 2030
• North America was the largest regional market in2022 due to the strong presence of several pharmaceutical players in the U.S.
• On the other hand, the market in Asia Pacific is projected to register the fastest CAGR from 2023 to 2030

Bioanalytical Testing Services Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 4,264.0 million
Revenue forecast in 2030	USD 7,645.7 million
Growth rate	CAGR of 8.7% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 – 2021
Forecast period	2023 – 2030

List of Key Players of Bioanalytical Testing Services Market

• PPD, Inc.
• ICON Plc
• Charles River Laboratories International
• Covance, Inc.
• IQVIA
• Syneos Health
• SGS SA
• Toxikon
• Intertek Group Plc
• Pace Analytical Services LLC

Access Press Release of Bioanalytical Testing Services Market @ https://www.grandviewresearch.com/press-release/global-bioanalytical-testing-services-market

Embolic Protection Devices Market Segmented On The Basis Of Product, Application, Region And Forecast 2026: Grand View Research Inc.

San Francisco, 23 Nov 2023: The Report Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion, Proximal Occlusion Systems), By Application (CVDs, Neurovascular Diseases), And Segment Forecasts, 2018 – 2026

The global embolic protection devices market size is expected to reach USD 1.7 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.4% during the forecast period. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion. The number of TAVR centers in U.S. has increased from 156 in 2012 to 511 in 2017, and approximately 35,000 patients underwent TAVR in 2016 in U.S. alone. The distal occlusion systems segment is expected to register the highest CAGR over the forecast period.

Access Research Report of Embolic Protection Devices Market @ https://www.grandviewresearch.com/industry-analysis/embolic-protection-devices-market

Further key findings from the study suggest:

• Distal filter devices segment emerged as the largest segment owing to high demand for these devices
• Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders
• North America led the global embolic protection devices market with the largest share in 2017 and is likely to maintain this trend over the estimated period
• Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region
• The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base
• Some of the key companies include Boston Scientific Corp.; Edward Lifesciences; Abbott Laboratories; Medtronic Plc; Cardinal Health, Inc.; Claret Medical, Inc.; and Innovative Cardiovascular Solutions, LLC

Access Press Release of Embolic Protection Devices Market @ https://www.grandviewresearch.com/press-release/global-embolic-protection-devices-market